Clinical trial
Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)
NCT00177684 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00177684 |
|---|---|
| Title | Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®) |
| Official title | Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®) |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Enzon Pharmaceuticals, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Transplantation, Fungal Infections |
| Intervention type | Drug |
| Interventions | Amphotericin B |
| Enrollment | 48 |
| Start date | Sep 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 17, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: